This inventor holds 1 USPTO granted patent and 8 published patent applications and 1 EPO patent. Top assignee: Shanghai Benemae Pharmaceutical Corporation. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations in Coagulation Treatment by Xiaowu Liu
Introduction
Xiaowu Liu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the area of coagulation treatment. His innovative work has led to the development of a unique antibody that targets coagulation factors, which is crucial for treating various medical conditions.
Latest Patents
Xiaowu Liu holds a patent for an anti-coagulation factor XI antibody. This patent discloses antibodies that bind to coagulation factor XI (FXI) and its activated form, factor XIa (FXIa). The patent also includes methods for preparing these antibodies and their use in treating and preventing conditions associated with thrombosis, such as complications arising from blood clots.
Career Highlights
Xiaowu Liu is associated with Shanghai Benemae Pharmaceutical Corporation, where he continues to advance his research and development efforts. His work is pivotal in creating therapeutic solutions that address coagulation-related health issues.
Collaborations
Xiaowu Liu collaborates with notable colleagues, including Wenyi Wang and Quan Yu. Their combined expertise enhances the research and development processes at their organization.
Conclusion
Xiaowu Liu's innovative contributions to the field of coagulation treatment exemplify the impact of targeted therapies in modern medicine. His work not only advances scientific knowledge but also holds the potential to improve patient outcomes significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile